Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (31 ops.)
Latest filing published 14 May 2026 for Apellis Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleA. Sinclair Dunlop
Insider track record
Disclosed buys
0
Disclosed sells
31
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
A. Sinclair Dunlop: trading record in brief
A. Sinclair Dunlop, listed as senior executive, appears in our data through filings on Apellis Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 50 filings cover trades dated from 13 November 2017 to 14 May 2026.
On the market, this insider has only sold: 31 sales, €19.7M in total. Other entries cover 5 share grants and 9 option exercises.
The newest entry dates from 14 May 2026: a transaction, in Apellis Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to A. Sinclair Dunlop
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations37 total
161,567 sharesCommon StockSEC:0001193125-26-224633:0
7,961 shares0Common StockSEC:0001492422-26-000013:0
4,787 shares0Common StockSEC:0001193125-25-240563:0
31,092 shares@ US$22.585.3% of flowCommon StockSEC:0001193125-25-228277:0
31,092 shares@ US$22.955.7% of flowCommon StockSEC:0001193125-25-209537:0
6,267 shares0Common StockSEC:0001127602-25-000419:0
4,600 shares@ US$13.190.5% of flowCommon StockSEC:0001127602-24-024373:0
29,476 shares@ US$36.099.5% of flowCommon StockSEC:0000950170-24-107411:0
7,524 shares@ US$36.792.5% of flowCommon StockSEC:0000950170-24-107411:1
900 shares@ US$13.190.1% of flowCommon StockSEC:0001127602-24-019521:0
35,305 shares@ US$39.2212.8% of flowCommon StockSEC:0000950170-24-076423:0
1,500 shares@ US$13.190.2% of flowCommon StockSEC:0001127602-24-012884:0
18,681 shares@ US$57.1799.7% of flowCommon StockSEC:0000950170-24-034277:0
3,341 shares0Common StockSEC:0001127602-24-000110:0
6,274 shares@ US$13.190.8% of flowCommon StockSEC:0001127602-23-029691:0
24,000 shares@ US$61.13513.3% of flowCommon StockSEC:0000950170-23-068183:0
24,000 shares@ US$49.0011.0% of flowCommon StockSEC:0000899243-23-020450:0
8,894 shares@ US$49.9914.1% of flowCommon StockSEC:0001127602-23-028142:0
500 shares@ US$74.050.3% of flowCommon StockSEC:0001127602-23-012600:0
500 shares@ US$65.330.3% of flowCommon StockSEC:0001127602-23-008357:0
500 shares@ US$52.610.2% of flowCommon StockSEC:0001127602-23-003104:0
500 shares@ US$50.700.2% of flowCommon StockSEC:0001127602-23-001000:0
3,867 shares0Common StockSEC:0000899243-23-000673:0
500 shares@ US$49.930.2% of flowCommon StockSEC:0000899243-22-037440:0
500 shares@ US$60.830.3% of flowCommon StockSEC:0000899243-22-034916:0
25 of 37 declarations
